A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
Recruiting now
Conditions studied: Multiple Myeloma, M Protein
In brief
By using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments. And exploring the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.
Key facts
- Study ID
- NCT06082284
- Run by
- Zhujiang Hospital
- People needed
- 10000
- Starts
- 2023-10-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2024-12-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients attending the outpatient/emergency/inpatient department of Zhujiang Hospital;
- Age: over 18 years old;
- There are sufficient remaining serum samples and extensive informed consent has been signed.
You may not qualify if…
- Early diagnosis of hematological diseases such as plasma cell or other B lymphocyte proliferative diseases；
- Improper storage or repeated freeze-thaw of remaining serum samples.
Where it is running
- Zhujiang Hospital of Southern Medical University — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.